Assessment of Tumor Prevention in Type 1 Neurofibromatosis using a Nitroxide Compound

These data reveal that oral antioxidant therapy with CTMIO does not reduce tumor formation in a multistage cancer model, but also that this model does not feature LOH for Nf1.